<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Most patients with cerebral sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (CST) recover after treatment with <z:chebi fb="5" ids="28304">heparin</z:chebi>, but a subgroup has a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Those patients may benefit from endovascular thrombolysis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Prospective case series </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> were selected for thrombolysis if they had an <z:e sem="disease" ids="C0278061" disease_type="Mental or Behavioral Dysfunction" abbrv="">altered mental status</z:e>, <z:hpo ids='HP_0001259'>coma</z:hpo>, straight sinus <z:mp ids='MP_0005048'>thrombosis</z:mp>, or large space-occupying lesions </plain></SENT>
<SENT sid="4" pm="."><plain>Urokinase was infused into the sinuses (bolus 120 to 600 x 10(3) U; then 100 x 10(3) U/h) via a jugular catheter, in 15 cases combined with mechanical <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> disruption or removal </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We treated 20 patients (16 women), mean age 32 years </plain></SENT>
<SENT sid="6" pm="."><plain>Twelve patients were <z:e sem="disease" ids="C0009421" disease_type="Disease or Syndrome" abbrv="">comatose</z:e> and 14 had hemorrhagic <z:mpath ids='MPATH_124'>infarcts</z:mpath> before thrombolysis </plain></SENT>
<SENT sid="7" pm="."><plain>Twelve patients recovered (Rankin score 0 to 2), 2 survived with handicaps, and 6 died </plain></SENT>
<SENT sid="8" pm="."><plain>Factors associated with a fatal outcome were <z:hpo ids='HP_0001909'>leukemia</z:hpo> (3/6 versus 0/14, P=0.02) and large hemorrhagic <z:mpath ids='MPATH_124'>infarcts</z:mpath> (4/6 versus 2/14, P=0.04) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001250'>Seizures</z:hpo> were less frequent in the fatal cases (P=0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Patients who died had a larger mean lesion surface than survivors (30.5 versus 13.6 cm(2); P=0.03), larger midline shift (5.2 versus 1.7 mm; P=0.02), and a more rapid course (2.7 versus 8.2 days; P=0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>Five patients who died had large hemispheric <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0000969'>edema</z:hpo> before thrombolysis, causing <z:e sem="disease" ids="C0019270" disease_type="Disease or Syndrome" abbrv="">herniation</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Five patients had increased <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> (3 minor, 2 major) after thrombolysis </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Thrombolysis can be effective for severe sinus <z:mp ids='MP_0005048'>thrombosis</z:mp>, but patients may deteriorate because of increased <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Patients with large <z:mpath ids='MPATH_124'>infarcts</z:mpath> and impending <z:e sem="disease" ids="C0019270" disease_type="Disease or Syndrome" abbrv="">herniation</z:e> did not benefit </plain></SENT>
</text></document>